Performance of FDG PET/CT in the clinical management of breast cancer
In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/...
Saved in:
| Published in: | Radiology Vol. 266; no. 2; p. 388 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.02.2013
|
| Subjects: | |
| ISSN: | 1527-1315, 1527-1315 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given. |
|---|---|
| AbstractList | In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given.In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given. In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given. |
| Author | Hindié, Elif Giacchetti, Sylvie Groheux, David Espié, Marc |
| Author_xml | – sequence: 1 givenname: David surname: Groheux fullname: Groheux, David email: dgroheux@yahoo.fr organization: Department of Nuclear Medicine and Department of Medical Oncology, Breast Diseases Unit, Saint-Louis Hospital, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France. dgroheux@yahoo.fr – sequence: 2 givenname: Marc surname: Espié fullname: Espié, Marc – sequence: 3 givenname: Sylvie surname: Giacchetti fullname: Giacchetti, Sylvie – sequence: 4 givenname: Elif surname: Hindié fullname: Hindié, Elif |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23220901$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNjztPwzAUhS1URB8wsyGPLGl9r-NHR1TaglSJDmWOHOcGghKnOOnAv28risR0zvB9RzpjNghtIMbuQUwBUjuLrqjaegoIIKySV2wECk0CEtTgXx-ycdd9CQGpsuaGDVEiirmAEVtuKZZtbFzwxNuSr57XfLvczRY7XgXefxL3dRUq72p-YtwHNRT6M5hHcl3P_VmMt-y6dHVHd5ecsPfVcrd4STZv69fF0ybxUss-Qcpp7qVXKSrvzbx0JSqnPRTG5iiM9Zq08s5pLaBEQExdoVOtTSmV1Q4n7PF3dx_b7wN1fdZUnae6doHaQ5cBWokG9MmcsIcLesgbKrJ9rBoXf7K_63gEI35bYg |
| CitedBy_id | crossref_primary_10_1007_s13139_016_0437_6 crossref_primary_10_4103_ijnm_ijnm_183_22 crossref_primary_10_1016_j_jacr_2023_02_016 crossref_primary_10_1016_j_anl_2020_01_002 crossref_primary_10_1016_j_ejrad_2020_108975 crossref_primary_10_1088_2057_1976_1_1_015202 crossref_primary_10_1016_j_pec_2015_02_012 crossref_primary_10_12998_wjcc_v12_i11_1885 crossref_primary_10_1007_s12282_015_0613_z crossref_primary_10_1016_j_ejrnm_2014_07_006 crossref_primary_10_1186_s13058_025_02087_6 crossref_primary_10_1016_j_jacr_2022_02_010 crossref_primary_10_4103_ijmr_IJMR_1368_16 crossref_primary_10_1007_s11605_013_2291_5 crossref_primary_10_1016_j_bulcan_2025_02_014 crossref_primary_10_2217_nnm_2018_0168 crossref_primary_10_1007_s12149_018_1307_3 crossref_primary_10_1093_jjco_hyad032 crossref_primary_10_1186_s12880_018_0254_8 crossref_primary_10_1002_cplu_202400095 crossref_primary_10_1016_j_nima_2015_10_071 crossref_primary_10_3390_biomedicines10030667 crossref_primary_10_1007_s00259_024_06866_9 crossref_primary_10_1088_1361_6560_aaa44c crossref_primary_10_1007_s00259_016_3402_9 crossref_primary_10_3389_fonc_2023_1149791 crossref_primary_10_1016_j_cpet_2023_12_002 crossref_primary_10_1186_s40644_020_00325_y crossref_primary_10_3390_diagnostics11111954 crossref_primary_10_1016_j_mpsur_2015_10_004 crossref_primary_10_1093_jncimonographs_lgv013 crossref_primary_10_1097_RCT_0000000000001020 crossref_primary_10_1007_s12149_018_1259_7 crossref_primary_10_1016_j_gynor_2013_06_003 crossref_primary_10_1371_journal_pone_0176782 crossref_primary_10_1038_s41598_020_78865_3 crossref_primary_10_1007_s00259_014_2941_1 crossref_primary_10_4103_ijc_IJC_1202_20 crossref_primary_10_1038_s41598_024_78383_6 crossref_primary_10_1016_j_jacr_2017_08_037 crossref_primary_10_1186_s13550_018_0466_5 crossref_primary_10_1007_s00259_019_4259_5 crossref_primary_10_1016_j_radphyschem_2018_01_019 crossref_primary_10_1186_1471_2407_14_272 crossref_primary_10_1371_journal_pone_0094017 crossref_primary_10_5306_wjco_v5_i5_982 crossref_primary_10_1007_s12282_016_0685_4 crossref_primary_10_1007_s10549_014_3072_x crossref_primary_10_1097_MNM_0000000000000928 crossref_primary_10_1016_j_acra_2015_02_012 crossref_primary_10_1097_MNM_0000000000000768 crossref_primary_10_1684_bdc_2013_1847 crossref_primary_10_1002_hep_26781 crossref_primary_10_1007_s00259_025_07460_3 crossref_primary_10_3892_etm_2024_12788 crossref_primary_10_1007_s12149_019_01364_7 crossref_primary_10_1097_MNM_0000000000001610 crossref_primary_10_1016_j_ejrad_2014_05_037 crossref_primary_10_1007_s00259_017_3705_5 crossref_primary_10_1007_s00259_017_3709_1 crossref_primary_10_1016_j_mednuc_2019_10_002 crossref_primary_10_1016_j_mednuc_2014_05_004 crossref_primary_10_1016_j_mednuc_2014_05_005 crossref_primary_10_1097_RLU_0000000000004491 crossref_primary_10_1016_j_clinimag_2017_06_001 crossref_primary_10_1016_j_breastdis_2016_01_019 crossref_primary_10_1245_s10434_015_4403_9 crossref_primary_10_1007_s11604_020_00966_w crossref_primary_10_1007_s12253_019_00641_0 crossref_primary_10_1038_s41598_017_01524_7 crossref_primary_10_3389_fonc_2022_1007874 crossref_primary_10_1007_s00259_024_06696_9 crossref_primary_10_4274_BMB_galenos_2025_69885 crossref_primary_10_1097_RLI_0000000000000197 crossref_primary_10_1007_s13139_016_0446_5 crossref_primary_10_1016_j_cpet_2023_04_006 crossref_primary_10_1053_j_ro_2018_08_007 crossref_primary_10_1097_MNM_0000000000000779 crossref_primary_10_3390_cancers14092103 crossref_primary_10_1080_10717544_2017_1399299 crossref_primary_10_1097_MD_0000000000015925 crossref_primary_10_1097_MNM_0000000000000661 crossref_primary_10_1007_s10549_014_3007_6 crossref_primary_10_1007_s00330_015_3630_6 crossref_primary_10_1097_MNM_0000000000001073 crossref_primary_10_3348_kjr_2015_16_2_219 crossref_primary_10_1016_j_soncn_2017_08_008 crossref_primary_10_1053_j_semnuclmed_2020_07_002 crossref_primary_10_1038_s41598_022_05166_2 crossref_primary_10_1186_1471_2407_13_538 crossref_primary_10_1093_jbi_wbae053 crossref_primary_10_1148_radiol_2021204677 crossref_primary_10_1186_s13014_020_01576_6 crossref_primary_10_1634_theoncologist_2014_0342 crossref_primary_10_3389_fmed_2016_00019 crossref_primary_10_23736_S1824_4785_19_03114_5 crossref_primary_10_1186_s40644_022_00468_0 crossref_primary_10_1097_RLU_0000000000000754 crossref_primary_10_1371_journal_pone_0120303 crossref_primary_10_1016_j_drudis_2021_07_025 crossref_primary_10_1259_bjr_20150268 crossref_primary_10_1053_j_semnuclmed_2024_01_007 crossref_primary_10_1016_j_ejca_2014_04_020 crossref_primary_10_1186_s13550_018_0359_7 crossref_primary_10_1007_s10549_016_4022_6 crossref_primary_10_1007_s10544_017_0173_4 crossref_primary_10_1016_S0959_8049_14_70068_1 crossref_primary_10_1016_j_cpet_2018_02_003 crossref_primary_10_1007_s40336_021_00426_z crossref_primary_10_1016_j_cpet_2014_12_004 crossref_primary_10_1097_IOP_0000000000000115 crossref_primary_10_1007_s11307_017_1150_2 crossref_primary_10_1097_MNM_0000000000001726 crossref_primary_10_1007_s00259_014_2689_7 crossref_primary_10_1097_MNM_0000000000000910 crossref_primary_10_1186_s40658_020_00351_6 crossref_primary_10_1097_RUQ_0000000000000535 crossref_primary_10_1200_JCO_24_01945 crossref_primary_10_1016_j_cpet_2014_09_007 crossref_primary_10_1002_pro6_1245 crossref_primary_10_1016_j_ejrad_2015_03_026 crossref_primary_10_1007_s12149_021_01604_9 crossref_primary_10_1007_s12254_015_0210_z crossref_primary_10_1245_s10434_015_4526_z crossref_primary_10_1002_jmri_26298 crossref_primary_10_1007_s00259_018_4102_4 crossref_primary_10_1007_s00259_016_3430_5 crossref_primary_10_1007_s10549_014_2924_8 crossref_primary_10_1016_j_ejrad_2022_110334 crossref_primary_10_1097_RLU_0000000000003690 crossref_primary_10_1053_j_semnuclmed_2015_03_003 crossref_primary_10_1111_tbj_12570 crossref_primary_10_4329_wjr_v8_i8_743 crossref_primary_10_1016_j_breast_2024_103806 crossref_primary_10_1007_s00259_013_2553_1 crossref_primary_10_1200_JCO_2014_60_0353 crossref_primary_10_1007_s11307_018_1181_3 crossref_primary_10_1007_s11604_018_0785_5 crossref_primary_10_1007_s40336_022_00517_5 crossref_primary_10_1016_j_mednuc_2015_03_003 crossref_primary_10_1016_j_suronc_2021_101567 crossref_primary_10_1158_1078_0432_CCR_22_2720 crossref_primary_10_1007_s40336_019_00319_2 crossref_primary_10_4103_aort_aort_15_25 crossref_primary_10_1053_j_semnuclmed_2022_05_001 crossref_primary_10_1007_s13139_017_0485_6 crossref_primary_10_1007_s12149_019_01422_0 crossref_primary_10_1038_s43018_021_00223_7 crossref_primary_10_1002_acm2_13483 crossref_primary_10_1016_j_mednuc_2018_12_012 crossref_primary_10_1097_MD_0000000000000115 crossref_primary_10_1016_j_breast_2023_06_011 crossref_primary_10_1007_s00259_013_2600_y crossref_primary_10_2217_fon_2019_0017 crossref_primary_10_1097_MNM_0000000000000217 crossref_primary_10_1097_MNM_0000000000000578 crossref_primary_10_1016_j_senol_2024_100629 crossref_primary_10_1016_j_cpet_2018_02_011 crossref_primary_10_1186_s40658_019_0256_9 crossref_primary_10_1016_j_mpsur_2019_01_011 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1148/radiol.12110853 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-1315 |
| ExternalDocumentID | 23220901 |
| Genre | Journal Article Review |
| GroupedDBID | --- .55 .GJ 123 18M 1CY 1KJ 29P 2WC 34G 39C 4.4 53G 5RE 6NX 6PF 7FM AAEJM AAQQT AAWTL ABDPE ABHFT ABOCM ACFQH ACGFO ACJAN ADBBV AENEX AENYM AFFNX AFOSN AJJEV AJWWR ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P F9R GX1 H13 J5H KO8 L7B LMP LSO MJL MV1 N4W NPM OK1 P2P R.V RKKAF RXW SJN TAE TR2 TRS TWZ W8F WH7 WOQ X7M YQI YQJ ZGI ZVN ZXP 7X8 |
| ID | FETCH-LOGICAL-c363t-2ebe9c3c5425cc79faf25a6c1d78b2078c6e65caa6601f21224ad64667f3586a2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 199 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000314221700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1527-1315 |
| IngestDate | Fri Sep 05 12:59:40 EDT 2025 Mon Jul 21 05:56:37 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c363t-2ebe9c3c5425cc79faf25a6c1d78b2078c6e65caa6601f21224ad64667f3586a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 23220901 |
| PQID | 1283271612 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1283271612 pubmed_primary_23220901 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-Feb 20130201 |
| PublicationDateYYYYMMDD | 2013-02-01 |
| PublicationDate_xml | – month: 02 year: 2013 text: 2013-Feb |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Radiology |
| PublicationTitleAlternate | Radiology |
| PublicationYear | 2013 |
| SSID | ssj0014587 |
| Score | 2.5093157 |
| SecondaryResourceType | review_article |
| Snippet | In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 388 |
| SubjectTerms | Breast Neoplasms - diagnostic imaging Breast Neoplasms - pathology Breast Neoplasms - therapy Diagnosis, Differential Female Fluorodeoxyglucose F18 - pharmacokinetics Humans Multimodal Imaging Neoplasm Recurrence, Local Neoplasm Staging Positron-Emission Tomography Radiopharmaceuticals - pharmacokinetics Sentinel Lymph Node Biopsy Tomography, X-Ray Computed |
| Title | Performance of FDG PET/CT in the clinical management of breast cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23220901 https://www.proquest.com/docview/1283271612 |
| Volume | 266 |
| WOSCitedRecordID | wos000314221700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ07T8MwEMdPQBFi4f0oLxmJ1Wpsx04yIVRaWFplKFK3yHFsqRIkfcHn55ymdEJCYskUS9H57PzOd74_wINVgQ2KIqS5ZjENnZVUS6lx4SXIIw7jljyuxSai4TAej5O0OXBbNGWV6z2x3qiLyvgz8g7zmjoI94w_TmfUq0b57GojobENLYEo4706Gm-yCKGsBfK8citlgsmmtQ9GAJ25LibVu--t4Mvvxe98Wf9n-of__cIjOGgIkzytXOIYtmx5AnuDJod-Cr10c1eAVI70n19I2ht1uiMyKQnyIFnfliQfP7Ux_sXc168vifED52fw1u-Nuq-0EVOgRiixpBxnKzHCSFykxkSJ045LrQwrcDo4goJRVkmjtcIQzXGfcNOFCpWKnJCx0vwcdsqqtJdAEkS2SLHcREqHwtq8SGxuLEfYYIEQvA33awNl6Kw-A6FLW30uso2J2nCxsnI2XXXVyBDteIB0cvWH0dewz2tZCl9WcgMth0vV3sKu-VpOFvO72gvwOUwH36YOulg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Performance+of+FDG+PET%2FCT+in+the+clinical+management+of+breast+cancer&rft.jtitle=Radiology&rft.au=Groheux%2C+David&rft.au=Espi%C3%A9%2C+Marc&rft.au=Giacchetti%2C+Sylvie&rft.au=Hindi%C3%A9%2C+Elif&rft.date=2013-02-01&rft.issn=1527-1315&rft.eissn=1527-1315&rft.volume=266&rft.issue=2&rft.spage=388&rft_id=info:doi/10.1148%2Fradiol.12110853&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-1315&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-1315&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-1315&client=summon |